Showing results (11-20 of 50) with videos related to
Sort By:
Pageof 5
The Journal of Nutrition, Health & Aging|March 23, 2010
Seeing with new eyes: finding a path to early intervention trials in Alzheimer's diseaseJ M Cedarbaum, G Crans, M GrundmanJournal of Neurology, Neurosurgery, and Psychiatry|February 1, 1989
A double-blind crossover comparison of Sinemet CR4 and standard Sinemet 25/100 in patients with Parkinson's disease and fluctuating motor performanceJ M Cedarbaum, M Hoey, F H McDowellNeurology|April 1, 1988
Clinical significance of the relationship between O-methyldopa levels and levodopa intakeJ M Cedarbaum, H Kutt, F H McDowellNeurology|November 1, 1989
A pharmacokinetic and pharmacodynamic comparison of Sinemet CR (50/200) and standard Sinemet (25/100)J M Cedarbaum, H Kutt, F H McDowellRevue Neurologique|January 1, 1988
Energy metabolism in disorders of the nervous systemJ P Blass, R K Sheu, J M CedarbaumNeurology|May 1, 1991
"Early" initiation of levodopa treatment does not promote the development of motor response fluctuations, dyskinesias, or dementia in Parkinson's diseaseJ M Cedarbaum, S E Gandy, F H McDowellAnnals of Neurology|May 1, 1991
Temporal relationships between plasma and cerebrospinal fluid pharmacokinetics of levodopa and clinical effect in Parkinson's diseaseC W Olanow, L L Gauger, J M CedarbaumClinical Neuropharmacology|December 1, 1990
Effect of nitecapone (OR-462) on the pharmacokinetics of levodopa and 3-O-methyldopa formation in cynomolgus monkeysJ M Cedarbaum, G Léger, A Reches, et al.Clinical Neuropharmacology|June 1, 1991
L-deprenyl (selegiline) added to Sinemet CR in the management of Parkinson's disease patients with motor response fluctuationsJ M Cedarbaum, L H Toy, A Green-ParsonsNeurology|October 1, 1987
Controlled-release levodopa/carbidopa. II. Sinemet CR4 treatment of response fluctuations in Parkinson's diseaseJ M Cedarbaum, L Breck, H Kutt, et al.Pageof 5